A CD36 neutralizing antibody inhibited metastasis of human melanoma and breast cancer cells[72], and inhibition of CPT1 caused mitochondrial damage leading to cell death in primary AML cells[67]. This evidence concerns the gene CPT1A and acute myeloid leukemia.